Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 1
2006 2
2007 1
2008 4
2009 5
2010 9
2011 2
2013 2
2015 7
2016 6
2017 3
2018 2
2019 9
2020 11
2021 11
2022 10
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Antineoplastic Effects of Ankaferd Hemostat.
Malkan UY, Haznedaroglu IC. Malkan UY, et al. Among authors: haznedaroglu ic. Biomed Res Int. 2022 Aug 2;2022:2665903. doi: 10.1155/2022/2665903. eCollection 2022. Biomed Res Int. 2022. PMID: 35958818 Free PMC article. Review.
Covid-19 scientific publications from Turkey.
Çiftçiler R, Haznedaroğlu İC, Tufan A, Öztürk MA. Çiftçiler R, et al. Among authors: haznedaroglu ic. Turk J Med Sci. 2021 Jun 28;51(3). doi: 10.3906/sag-2010-261. Turk J Med Sci. 2021. PMID: 33306333 Free article. Review.
Ankaferd hemostat: from molecules to medicine.
Çiftçiler R, Haznedaroglu İC. Çiftçiler R, et al. Among authors: haznedaroglu ic. Turk J Med Sci. 2020 Nov 3;50(SI-2):1739-1750. doi: 10.3906/sag-1908-161. Turk J Med Sci. 2020. PMID: 32283900 Free PMC article. Review.
Perspectives for immune plasma treatment of COVID-19.
Sayinalp B, Çinar OE, Haznedaroğlu İC. Sayinalp B, et al. Among authors: haznedaroglu ic. Turk J Med Sci. 2021 Feb 26;51(1):1-9. doi: 10.3906/sag-2005-410. Turk J Med Sci. 2021. PMID: 32718128 Free PMC article. Review.
Review on Characteristics and Analytical Methods of Rivaroxaban.
Reçber T, Haznedaroğlu İC, Çelebier M. Reçber T, et al. Among authors: haznedaroglu ic. Crit Rev Anal Chem. 2022;52(4):865-877. doi: 10.1080/10408347.2020.1839735. Epub 2020 Nov 4. Crit Rev Anal Chem. 2022. PMID: 33146024 Review.
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Saydam G, Ali R, Demir AM, Eskazan AE, Guvenc B, Haznedaroglu IC, Ozcan MA, Salim O, Sonmez M, Tuglular AT, Turgut M, Unal A, Aver B, Bozkurt S, Ozdengulsun B, Ilhan O. Saydam G, et al. Among authors: haznedaroglu ic. Int J Hematol Oncol. 2022 May 24;11(1):IJH38. doi: 10.2217/ijh-2021-0010. eCollection 2022 Mar. Int J Hematol Oncol. 2022. PMID: 35664044 Free PMC article. Review.
80 results